Clinical Trial Update: Study to Compare Conivaptan in Subjects With Mild & Moderate Liver Impairment Versus Subjects With Normal Liver Function [Phase 1]

View source ↗

Summary

Phase 1 trial update comparing conivaptan pharmacokinetics in subjects with mild to moderate liver impairment versus those with normal liver function. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyponatremia
• Liver Disease

Drugs mentioned

• Conivaptan (conivaptan)

Snippet

Sponsor: Cumberland Pharmaceuticals | Conditions: Liver Disease, Hyponatremia | Phase 1 | Status: COMPLETED